Literature DB >> 9731289

Corynebacterium thomssenii sp. nov., a Corynebacterium with N-acetyl-beta-glucosaminidase activity from human clinical specimens.

O Zimmermann1, C Spröer, R M Kroppenstedt, E Fuchs, H G Köchel, G Funke.   

Abstract

A strain of a previously undescribed non-lipophilic coryneform bacterium was isolated from pleural fluids of a patient with chronic renal failure, stroke and pneumonia. Slow fermentative acid production from glucose, maltose and sucrose, and strong N-acetyl-beta-glucosaminidase activity were the most characteristic features of the bacterium. Chemotaxonomic characterization unambiguously indicated that the organism belonged to the genus Corynebacterium. The results of comparative 16S rRNA gene sequence analysis revealed that the isolate represented a new species within the genus, for which the name Corynebacterium thomssenii sp. nov. is proposed. The type strain is DSM 44276.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731289     DOI: 10.1099/00207713-48-2-489

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  4 in total

1.  Characteristics of rare or recently described corynebacterium species recovered from human clinical material in Canada.

Authors:  K A Bernard; C Munro; D Wiebe; E Ongsansoy
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Isolation and characterization of a black-pigmented Corynebacterium sp. from a woman with spontaneous abortion.

Authors:  S K Shukla; D N Vevea; D N Frank; N R Pace; K D Reed
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and "nonbacterial" prostatitis.

Authors:  M A Tanner; D Shoskes; A Shahed; N R Pace
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Phenotypic and phylogenetic characterization of a new Corynebacterium species from dogs: description of Corynebacterium auriscanis sp. nov.

Authors:  M D Collins; L Hoyles; P A Lawson; E Falsen; R L Robson; G Foster
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.